Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Phospho flow cytometry methods for the analysis of kinase signaling in cell lines and primary human blood samples.

Krutzik PO, Trejo A, Schulz KR, Nolan GP.

Methods Mol Biol. 2011;699:179-202. doi: 10.1007/978-1-61737-950-5_9.

PMID:
21116984
2.

Single cell phospho-specific flow cytometry can detect dynamic changes of phospho-Stat1 level in lung cancer cells.

Lin CC, Huang WL, Su WP, Chen HH, Lai WW, Yan JJ, Su WC.

Cytometry A. 2010 Nov;77(11):1008-19. doi: 10.1002/cyto.a.20965.

3.

Quantification of intracellular proteins and monitoring therapy using flow cytometry.

Chang RL, Yeh CH, Albitar M.

Curr Drug Targets. 2010 Aug;11(8):994-9. Review.

PMID:
20426764
4.

Stage dependent aberrant regulation of cytokine-STAT signaling in murine systemic lupus erythematosus.

Hale MB, Krutzik PO, Samra SS, Crane JM, Nolan GP.

PLoS One. 2009 Aug 25;4(8):e6756. doi: 10.1371/journal.pone.0006756.

5.

Multiparameter phospho-flow analysis of lymphocytes in early rheumatoid arthritis: implications for diagnosis and monitoring drug therapy.

Galligan CL, Siebert JC, Siminovitch KA, Keystone EC, Bykerk V, Perez OD, Fish EN.

PLoS One. 2009 Aug 20;4(8):e6703. doi: 10.1371/journal.pone.0006703.

6.

Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells.

Karonitsch T, Feierl E, Steiner CW, Dalwigk K, Korb A, Binder N, Rapp A, Steiner G, Scheinecker C, Smolen J, Aringer M.

Arthritis Rheum. 2009 May;60(5):1463-71. doi: 10.1002/art.24449.

7.

Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates.

Kotecha N, Flores NJ, Irish JM, Simonds EF, Sakai DS, Archambeault S, Diaz-Flores E, Coram M, Shannon KM, Nolan GP, Loh ML.

Cancer Cell. 2008 Oct 7;14(4):335-43. doi: 10.1016/j.ccr.2008.08.014.

8.

Single-cell, phosphoepitope-specific analysis demonstrates cell type- and pathway-specific dysregulation of Jak/STAT and MAPK signaling associated with in vivo human immunodeficiency virus type 1 infection.

Lee AW, Sharp ER, O'Mahony A, Rosenberg MG, Israelski DM, Nolan GP, Nixon DF.

J Virol. 2008 Apr;82(7):3702-12. doi: 10.1128/JVI.01582-07. Epub 2008 Jan 23.

9.

Stat5 as a diagnostic marker for leukemia.

Lewis RS, Ward AC.

Expert Rev Mol Diagn. 2008 Jan;8(1):73-82. Review.

PMID:
18088232
10.

Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritis.

Martinez-Lostao L, Ordi-Ros J, Balada E, Segarra-Medrano A, Majó-Masferrer J, Labrador-Horrillo M, Vilardell-Tarrés M.

Lupus. 2007;16(7):483-8.

PMID:
17670846
11.

Activation of the STAT1 signalling pathway in lupus nephritis in MRL/lpr mice.

Dong J, Wang QX, Zhou CY, Ma XF, Zhang YC.

Lupus. 2007;16(2):101-9.

PMID:
17402366
12.

Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration.

Harada T, Kyttaris V, Li Y, Juang YT, Wang Y, Tsokos GC.

Autoimmunity. 2007 Feb;40(1):1-8.

PMID:
17364491
13.
14.
15.

Interferon pathway activation in systemic lupus erythematosus.

Crow MK.

Curr Rheumatol Rep. 2005 Dec;7(6):463-8. Review.

PMID:
16303107
16.

Prolactin signals via Stat5 and Oct-1 to the proximal cyclin D1 promoter.

Brockman JL, Schuler LA.

Mol Cell Endocrinol. 2005 Jul 15;239(1-2):45-53.

18.

Single cell profiling of potentiated phospho-protein networks in cancer cells.

Irish JM, Hovland R, Krutzik PO, Perez OD, Bruserud Ø, Gjertsen BT, Nolan GP.

Cell. 2004 Jul 23;118(2):217-28.

19.

Signal transducer and activator of transcription-5 activation and breast cancer prognosis.

Nevalainen MT, Xie J, Torhorst J, Bubendorf L, Haas P, Kononen J, Sauter G, Rui H.

J Clin Oncol. 2004 Jun 1;22(11):2053-60.

PMID:
15169792
20.

Series introduction. JAK-STAT signaling in human disease.

Schindler CW.

J Clin Invest. 2002 May;109(9):1133-7. Review. No abstract available.

Supplemental Content

Support Center